Alimentary pharmacology & therapeutics
-
Aliment. Pharmacol. Ther. · Mar 2015
Long-term outcomes of thalidomide in refractory Crohn's disease.
Several open-label and retrospective studies have indicated that thalidomide may be beneficial in patients with refractory Crohn's disease (CD). ⋯ Thalidomide appears to be safe and effective in some patients with refractory Crohn's disease. Although side effects may limit long-term use, thalidomide has potential to induce significant clinical responses.